4GT-20769-01462
2 vaccinations
8 coded responses
22 check-ins
8 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 56-60
- ZIP prefix
- 923 / CA
- Registered
- 2021-01-04
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-01-04
Registered in v-safe
-
2021-01-04
Dose 1 — Pfizer-BioNTech
- 2021-01-04
-
2021-01-05
Survey response — days 1–6 daily, dose 1MedDRA: Injection site pain — Feeling: Good · Site: Pain · FeverFree text: Mild Tenderness to palpation over injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-06
- 2021-01-07
- 2021-01-09
- 2021-01-10
- 2021-01-13
-
2021-01-18
Survey response — day 14, dose 1MedDRA: Nasal congestion, Oropharyngeal pain, Rhinalgia, Skin lesion — Feeling: GoodFree text: I had nasal congestion, nasal pain, a small lesion developed in my left nostril that was painful. I had a sore throat for one day (2 days ago).MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-26
Dose 2 — Pfizer-BioNTech
-
2021-01-26
Survey response — day 0, dose 2MedDRA: No adverse event — Feeling: Good · Site: Pain · Joint painsFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-27
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-28
Survey response — days 1–6 daily, dose 2MedDRA: Nasal congestion — Feeling: Fair · Fatigue or tirednessFree text: Nasal congestionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-29
Survey response — days 1–6 daily, dose 2MedDRA: Nasal congestion, Rhinalgia — Feeling: GoodFree text: Nasal congestion on one side with soreness of septumMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-30
Survey response — days 1–6 daily, dose 2MedDRA: Epistaxis, Nasal congestion, Secretion discharge — Feeling: GoodFree text: Nostril congestion and slight blood tinged mucous dischargeMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-01
Survey response — days 1–6 daily, dose 2MedDRA: Nasal congestion, Rhinalgia — Feeling: GoodFree text: Mild nasal congestion with sore inside right nostrilMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-03
Survey response — day 7, dose 2MedDRA: Rhinorrhoea — Feeling: GoodFree text: Still having blood tinged clear nasal discharge from right nostrilMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-09
- 2021-02-16
- 2021-02-23
- 2021-03-03
- 2021-04-27
- 2021-07-31
- 2022-01-26
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-04 | Pfizer-BioNTech | |
| 2 | 2021-01-26 | Pfizer-BioNTech |
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Mild Tenderness to palpation over injection site
Release 2 — day 14, dose 1
Symptoms: I had nasal congestion, nasal pain, a small lesion developed in my left nostril that was painful. I had a sore throat for one day (2 days ago).
Release 2 — day 0, dose 2
Systemic reaction (other): No
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): Nasal congestion
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Nasal congestion on one side with soreness of septum
Systemic reaction (other): Nostril congestion and slight blood tinged mucous discharge
Systemic reaction (other): Mild nasal congestion with sore inside right nostril
Release 3 — day 7, dose 2
Systemic reaction (other): Still having blood tinged clear nasal discharge from right nostril
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasal congestion | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Rhinalgia | ✓ | ✓ | ✓ |
| SD | Skin lesion | ✓ | ✓ | ✓ |
| SRO | Epistaxis | ✓ | ✓ | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
| SRO | Nasal congestion | ✓ | ✓ | ✓ |
| SRO | No adverse event | ✓ | ✓ | ✓ |
| SRO | Rhinalgia | ✓ | ✓ | ✓ |
| SRO | Rhinorrhoea | ✓ | ✓ | ✓ |
| SRO | Secretion discharge | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release